Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group
出版年份 2021 全文链接
标题
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group
作者
关键词
-
出版物
SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume 51, Issue 6, Pages 1378-1385
出版商
Elsevier BV
发表日期
2021-11-15
DOI
10.1016/j.semarthrit.2021.11.004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials
- (2021) Lisa K Stamp et al. Lancet Rheumatology
- Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis
- (2018) Lisa Stamp et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: Validation of a Definition of Flare in Patients With Established Gout
- (2018) Angelo L. Gaffo et al. Arthritis & Rheumatology
- Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
- (2018) Michael Doherty et al. LANCET
- Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians
- (2016) Amir Qaseem et al. ANNALS OF INTERNAL MEDICINE
- Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study)
- (2016) Kenneth G. Saag et al. Arthritis & Rheumatology
- An open-label, 6-month study of allopurinol safety in gout: The LASSO study
- (2015) Michael A. Becker et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
- (2012) Marissa N Lassere et al. BMC Medical Research Methodology
- Developing a provisional definition of flare in patients with established gout
- (2011) Angelo L. Gaffo et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Urate in Chronic Gout -- Will It Be the First Validated Soluble Biomarker in Rheumatology?
- (2011) L. K. STAMP et al. JOURNAL OF RHEUMATOLOGY
- Serum Urate as a Soluble Biomarker in Chronic Gout—Evidence that Serum Urate Fulfills the OMERACT Validation Criteria for Soluble Biomarkers
- (2010) Lisa K. Stamp et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria
- (2009) W. P. MAKSYMOWYCH et al. JOURNAL OF RHEUMATOLOGY
- Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design
- (2009) W. P. MAKSYMOWYCH et al. JOURNAL OF RHEUMATOLOGY
- Outcome Domains for Studies of Acute and Chronic Gout
- (2009) H. R. SCHUMACHER et al. JOURNAL OF RHEUMATOLOGY
- A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout
- (2007) W J Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started